Manifestations of Diseases / Sequelae (DM, Stroke, COPD, Trauma) — Clinical Documentation Guide (2026)

🔍 Definition

A sequela (plural: sequelae), also historically termed a late effect, is a residual condition or complication that arises as the direct result of a prior disease or injury after the acute phase has ended. Per ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.B.10, “A sequela is the residual effect (condition produced) after the acute phase of an illness or injury has terminated.” There is no time limit on when a sequela code may be assigned — the condition may appear soon after the precipitating event or many months to years later.

A manifestation is a clinical sign, symptom, or complication that arises as a direct result of an underlying disease process. In ICD-10-CM, manifestations of diseases are coded using the etiology/manifestation convention: the underlying disease (etiology) is coded first, and the associated manifestation is coded second. The Alphabetic Index signals this pairing by listing manifestation codes in [brackets], meaning the bracketed code cannot be reported as a principal diagnosis.

Key conditions covered in this guide:

• Diabetes Mellitus (DM): Combination codes (E11.2x–E11.8x) capture DM with specific manifestations (nephropathy, neuropathy, retinopathy, foot ulcer, etc.).
• Stroke / Cerebrovascular Disease: Sequelae of cerebrovascular disease (I69.x) represent residual neurological deficits after the acute event has resolved.
• COPD: Combination codes (J44.0, J44.1) capture COPD with acute lower respiratory infection or acute exacerbation, with additional causative organism coded separately.
• Trauma: 7th character extensions on injury codes (A = initial encounter, D = subsequent encounter, S = sequela) capture the phase of care for traumatic injuries and their late effects.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

The clinical presentation of disease manifestations and sequelae varies significantly by the underlying condition. Coders and CDI specialists should recognize these presentations as potential indicators of codeable conditions:

Diabetic Manifestations

• Neuropathy: Burning, tingling, or numbness in feet/hands; loss of protective sensation; Charcot foot deformity; autonomic neuropathy (gastroparesis, orthostatic hypotension, neurogenic bladder)
• Nephropathy: Proteinuria, declining GFR, edema, hypertension; progression to ESRD (CKD stage 5)
• Retinopathy: Visual blurring, floaters, sudden vision loss, macular edema; nonproliferative vs. proliferative stages
• Foot ulcer / skin complications: Non-healing wounds, ulcerations of lower extremity, gangrene; deep tissue necrosis
• Circulatory: Peripheral arterial disease, claudication, absent pedal pulses, rest pain

Stroke Sequelae

• Hemiplegia or hemiparesis (dominant vs. non-dominant side documentation is critical)
• Aphasia, dysphasia, dysarthria
• Dysphagia (swallowing difficulties requiring modified diet or tube feeding)
• Cognitive deficits, vascular dementia
• Depression following stroke
• Monoplegia of upper or lower limb
• Facial weakness, diplopia, visual field defects
• Ataxia, coordination difficulties, gait disturbances

COPD Manifestations

• Chronic productive cough, dyspnea on exertion, wheezing
• Acute exacerbation: worsening dyspnea, increased sputum production, change in sputum color/character
• Hypoxemia, hypercapnia requiring supplemental oxygen or mechanical ventilation
• Cor pulmonale, right heart failure
• Respiratory failure (Type I or II)
• Signs of superimposed infection: fever, purulent sputum, consolidation on imaging

Traumatic Sequelae

• Chronic pain at fracture site or soft tissue injury location
• Malunion or nonunion of fracture
• Post-traumatic arthritis
• Contractures from burn scarring; hypertrophic or keloid scars
• Chronic traumatic brain injury (TBI) effects: headache, cognitive changes, personality changes
• Post-traumatic osteomyelitis

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

Sequelae and Pathophysiologic Mechanisms: Sequelae arise because tissue damage from the primary disease or injury is permanent or only partially reversible. The underlying mechanisms include:

• Neuronal death (stroke): After ischemic infarction, neurons in the ischemic core die within minutes; the penumbra may recover with reperfusion. Permanent motor, sensory, or cognitive deficits reflect the permanent neuronal loss. Residual hemiplegia, aphasia, or dysphagia are structural sequelae of the irreversible infarct per NCBI StatPearls — Cerebral Infarction.
• Microvascular disease (DM): Chronic hyperglycemia causes glycation of basement membranes, endothelial dysfunction, and advanced glycation end-products (AGEs), leading to the classic triad of retinopathy, nephropathy, and neuropathy. These manifestations are direct complications of persistent DM and are coded as combination codes in ICD-10-CM per American Diabetes Association — Complications of Diabetes.
• Airway remodeling (COPD): Chronic inflammation and repeated injury from cigarette smoke, air pollution, and recurrent infections cause irreversible destruction of alveoli (emphysema) and chronic airway inflammation (bronchitis). Exacerbations represent acute decompensation superimposed on chronic remodeling per GOLD Guidelines 2025.
• Fibrotic repair (burns/trauma): After thermal injury or mechanical trauma, healing proceeds through inflammation, proliferative, and remodeling phases. Hypertrophic scar, keloid, or contracture formation represents disordered extracellular matrix deposition as a late complication of the original injury per NCBI StatPearls — Burn Wound Healing.

Etiology/Manifestation Convention in ICD-10-CM: The Alphabetic Index uses [brackets] to indicate manifestation codes that must always be sequenced second, after the etiology code. The underlying condition (etiology) drives the DRG assignment, HCC weight, and risk adjustment. Manifestation codes identified in brackets are never principal diagnosis on any claim.

💊 Medication Impact / Treatment

Medications used for underlying diseases often provide evidence supporting the presence of manifestations and sequelae. Coders and CDI specialists should recognize drug–diagnosis linkages:

Diabetes Manifestations

• ACE inhibitors / ARBs (lisinopril, losartan): first-line renoprotective agents in diabetic nephropathy — document CKD stage and link to DM (E11.22 + N18.x)
• Gabapentin / pregabalin / duloxetine: indicate diabetic peripheral neuropathy (E11.40–E11.49)
• Bevacizumab (Avastin) / anti-VEGF injections: treat diabetic macular edema — link to E11.311/E11.3211 (proliferative or non-proliferative DR with macular edema)
• Wound care orders / debridement: support diabetic foot ulcer coding (E11.621/E11.622 + L97.x)
• Insulin use: code Z79.4 (long-term insulin use) for Type 2 DM on insulin per CMS Guidelines Section I.C.4.a.3

Stroke Sequelae

• Physical therapy, occupational therapy, speech therapy orders: indicate active treatment of sequelae (hemiplegia, aphasia, dysphagia)
• Anticoagulation (warfarin, DOACs): may be for atrial fibrillation (cause of cardioembolic stroke) or DVT prophylaxis post-stroke; code underlying condition
• Antispasmodics (baclofen, tizanidine): indicate spasticity as sequela of stroke (I69.398 or I69.343)
• PEG tube/gastrostomy: supports dysphagia due to sequela (I69.391)

COPD

• Home oxygen therapy (Z99.81): indicates chronic hypoxemic respiratory failure in setting of COPD
• Systemic corticosteroids: indicate acute exacerbation (J44.1)
• Antibiotics: if given for COPD exacerbation with identified respiratory pathogen, supports J44.0 + specific organism code
• Bronchodilators (LAMA/LABA combinations): maintenance therapy; does not by itself indicate exacerbation
• Non-invasive positive pressure ventilation (BiPAP): with COPD indicates acute-on-chronic respiratory failure (J96.01); add this code when documented per CMS Guidelines Section I.C.10.a

Trauma Sequelae

• NSAIDs / opioid pain management: ongoing use at follow-up may indicate persistent pain as sequela (G89.21 post-traumatic chronic pain)
• Orthopedic hardware, revision surgery: late complication of fracture — use complication of internal fixation device codes (T84.xxx) vs. malunion codes (M84.3x)
• Compression garments, scar therapy: burn scar management — supports sequela coding (L90.5, T-code with 7th S)

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following official guidelines govern sequela and manifestation coding per the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting (CMS/NCHS):

Section I.B.10 — Sequelae (Late Effects)

A sequela is the residual effect produced after the acute phase of an illness or injury has terminated. There is no time limit on when a sequela code may be used; the residual may be apparent early or may occur many months or years later. Examples: scar formation after a burn; deficits from CVA; residual weakness from encephalitis.

• Sequencing rule: Code first the condition or nature of the sequela (the residual), then the cause of the sequela (the sequela code itself). Example: hemiplegia (I69.351) coded before sequela of cerebral infarction (if using expanded I69 code).
• Exception 1: When the sequela code itself has been expanded (at 4th, 5th, or 6th character) to include the manifestation, only the one code is needed. Example: I69.351 (Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side) includes both the residual and the cause in a single code.
• Exception 2: When the sequela code identifies the etiology at the 4th character level, no separate residual code is needed.

Section I.A.13 — Etiology/Manifestation Convention

Certain conditions have both an underlying etiology and multiple body system manifestations. The Alphabetic Index signals these relationships by placing manifestation codes in [brackets]. The tabular list includes instructional notes such as “Code first underlying disease” or “Use additional code.” Key rules:

• The etiology code is always sequenced first; the manifestation code second — this sequencing is mandatory and is not a “coder preference.”
• Manifestation codes in brackets can never be sequenced as a principal or first-listed diagnosis.
• The convention applies to conditions such as: DM with renal manifestation (E11.xx → N18.x), Alzheimer’s with dementia (G30.x → F02.8x), Parkinson’s with dementia (G20.x → F02.8x).

Section I.C.4 — Diabetes Mellitus

• Assign the most specific combination code. Do not code DM + manifestation as two separate codes if a combination code exists.
• Assume Type 2 if type is not documented (E11.x default per guidelines).
• Add Z79.4 (long-term insulin use) when Type 2 DM patient is on insulin. Do not use E11.x insulin-related code Z79.4 for Type 1 insulin-dependent patients — insulin use is inherent.
• For DM + CKD: code E11.22 + N18.x (CKD stage). Query for CKD stage if not documented.
• For DM + foot ulcer: code E11.621 (right foot) or E11.622 (left foot) + L97.x (ulcer location/severity).
• Multiple manifestations: code each applicable complication subcode (e.g., E11.40 + E11.22 + Z79.4).

Section I.C.9.d — Cerebrovascular Disease

• Category I63 (Cerebral infarction) is for the acute event only. Do not use I63.x when the acute phase has ended.
• Category I69 (Sequelae of cerebrovascular disease) is used when there are neurological deficits remaining after the acute phase. Subcategory I69.3 covers sequelae of cerebral infarction.
• Side documentation is critical: I69.351 = right dominant, I69.352 = left dominant, I69.353 = right non-dominant, I69.354 = left non-dominant. Query the provider when laterality and dominance are not documented.
• If a patient has acute CVA AND residual deficits from a prior CVA in the same admission, code both I63.x and I69.3xx.
• Z86.73 = personal history of TIA; use only when there are no residual neurological deficits.

Section I.C.10 — COPD / Respiratory

• J44.0 = COPD with acute lower respiratory infection; CODE ALSO the infection (J12–J18 for pneumonia, J20 for acute bronchitis). J44.0 is sequenced first per instructional note.
• J44.1 = COPD with (acute) exacerbation — used when documented as “acute exacerbation” or “AECOPD” without a confirmed superimposed infection.
• When acute respiratory failure is present with COPD exacerbation, sequence COPD first or respiratory failure first depending on the circumstances of admission per guidelines (principal diagnosis = condition most responsible for admission).
• J44.81 = Asthma-COPD overlap syndrome (ACOS) — do not separately code J44.x and J45.x when overlap is documented.

Section I.C.19 — Trauma / Injury Coding (7th Character Rules)

• 7th character A = Initial encounter — patient is receiving active treatment for the condition. Applies during ER visit, surgical procedure, or any active management of the injury.
• 7th character D = Subsequent encounter — patient has received active treatment; now receiving routine care during healing/recovery phase.
• 7th character S = Sequela — the acute injury has healed; patient now presents with a late complication or residual condition directly resulting from the injury. Sequence the residual condition first (e.g., M84.312 — malunion of fracture), then the S-coded injury code.
• For burns: use T-codes with 7th character S for late effects; add L90.5 (scar and fibrosis of skin), M24.5x (contracture of joint), or T86.820 (burn scar) as appropriate.

🔢 ICD-10-CM Code Set (FY2026)

🔎 Indexing

Using the ICD-10-CM Alphabetic Index correctly is essential for manifestation and sequela coding. Key entry points:

Sequela / Late Effect Index Entries

• Sequelae (of) — main term; subterms by condition type (burn, cerebrovascular disease, injury, infection)
• For stroke sequelae: Index → “Sequelae, cerebrovascular disease” → leads to I69.xx category with further subterms by type of deficit
• For traumatic sequelae: Index → injury code with note “code as sequela” when in follow-up phase with residual
• For burn late effects: Index → “Sequelae, burn and corrosion” → T95.x (older ICD-9 cross-reference approach) or specific burn code + 7th S

Etiology/Manifestation Index Entries

• Diabetes, diabetic (mellitus) → subterms (neuropathy, nephropathy, retinopathy, foot ulcer, etc.) → combination codes E11.xx shown with applicable add-codes in [brackets]
• Neuropathy, diabetic → leads back to E11.40–E11.49 series
• Retinopathy, diabetic → E11.311–E11.359 with macular edema subterms
• COPD → J44.9; “with acute bronchitis” → J44.0; “with acute exacerbation” → J44.1
• Hemiplegia, following cerebrovascular disease → I69.35x with laterality/dominance subterms
• Failure, heart → I50.9; with hypertension → I11.0 (required combination)

🏥 CPT (2026)

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The AHA Coding Clinic provides official guidance on ICD-10-CM/PCS coding questions. Key advisories relevant to manifestations and sequelae include:

• Coding Clinic, Q4 2017: Guidance on coding diabetic macular edema — when E11.311 is used, a separate code for macular edema (H35.81) is not needed unless the macular edema is in a different eye than the retinopathy.
• Coding Clinic, Q3 2018: COPD with pneumonia — confirmed that J44.0 is the correct code for COPD with acute lower respiratory infection; the specific pneumonia organism code should always be added per the instructional note.
• Coding Clinic, Q2 2016: Sequelae of stroke — confirms that I69.3xx is correct when residual deficits remain after the acute phase; discusses laterality documentation requirements for hemiplegia codes.
• Coding Clinic, Q1 2019: Traumatic 7th character clarification — the 7th character reflects the encounter type (active treatment vs. follow-up), not time elapsed since injury; a patient can receive active treatment months after initial injury and still use 7th character A.
• Coding Clinic, Q2 2020: DM with CKD — confirms E11.22 should be used with the appropriate N18.x code for CKD stage; queries for CKD stage documentation should be initiated when only “diabetic nephropathy” is documented without stage.
• Coding Clinic, Q3 2021: Hypertensive heart disease with CHF — reaffirms that ICD-10-CM presumes a causal relationship between hypertension and CHF (I11.0 + I50.x); do not code I10 and I50.x separately when both diagnoses are present.
• Coding Clinic, Q4 2022: Asthma-COPD overlap — guidance on use of J44.81 for documented overlap syndrome; avoid separate J44.x and J45.x codes when overlap is the documented diagnosis.

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (effective 2026), accurate coding of disease manifestations and sequelae is critical for appropriate risk adjustment. Sequelae codes often carry the full HCC weight of the underlying disease category:

✍️ CDI Query Templates

All queries below are written per AHIMA/ACDIS Compliant Query Guidelines: non-leading, multiple-choice, clinically supported, and documented in the medical record.

🧑‍⚕️ Treatments (Clinical)

Diabetic Manifestations — Treatment Overview

• Diabetic nephropathy: Tight glycemic control (target A1C per ADA Standards of Care 2024), ACE inhibitors or ARBs for renoprotection, sodium-glucose co-transporter-2 (SGLT2) inhibitors (empagliflozin, dapagliflozin) shown to reduce CKD progression, eventual hemodialysis or peritoneal dialysis for ESRD.
• Diabetic neuropathy: Optimize glycemic control; pharmacologic pain management (gabapentin, pregabalin, duloxetine, tricyclics); topical capsaicin; neuropathic foot care (protective footwear, podiatric follow-up per ADA Standards of Care 2024, Section 12).
• Diabetic retinopathy: Intravitreal anti-VEGF injections (ranibizumab, aflibercept) for proliferative retinopathy and macular edema; panretinal photocoagulation laser therapy; vitrectomy for advanced disease.
• Diabetic foot ulcer: Wound debridement (CPT 11042/11043), offloading (total contact cast), bioengineered skin substitutes, negative pressure wound therapy (VAC), vascular surgery consultation for PAD, osteomyelitis management if bone involved.

Stroke Sequelae — Rehabilitation

• Hemiplegia/hemiparesis: Inpatient rehabilitation facility (IRF) admission when able to tolerate 3+ hours therapy/day; physical therapy (gait training, strength), occupational therapy (ADLs, upper extremity function); constraint-induced movement therapy (CIMT) for upper extremity per AHA/ASA Stroke Rehabilitation Guidelines 2022.
• Aphasia: Speech-language pathology, high-intensity therapy, constraint-induced aphasia therapy; augmentative/alternative communication (AAC) devices.
• Dysphagia: Modified diet textures, nasogastric or PEG tube feeding, compensatory swallowing strategies.
• Spasticity: Oral baclofen, tizanidine; botulinum toxin injections (CPT 64612) for focal spasticity; intrathecal baclofen pump for severe cases.

COPD — Acute and Chronic Management

• Acute exacerbation (AECOPD): Short-acting bronchodilators (SABA + SAMA nebulization), systemic corticosteroids (5-day prednisone per GOLD 2025 Report), antibiotics if evidence of bacterial infection, supplemental oxygen targeting SpO2 88–92%, BiPAP for hypercapnic respiratory failure.
• Chronic COPD management: Long-acting bronchodilators (LAMA/LABA combination inhalers), inhaled corticosteroids (ICS) for frequent exacerbators (LABA/ICS/LAMA triple therapy), pulmonary rehabilitation, smoking cessation, pneumococcal and annual influenza vaccination.

Trauma Sequelae

• Malunion/nonunion of fracture: Surgical revision — corrective osteotomy, internal fixation, bone grafting; electrical bone stimulation.
• Post-traumatic arthritis: NSAIDs, intra-articular corticosteroids, eventual joint arthroplasty for severe cases.
• Burn scar/contracture: Serial splinting, pressure garments, scar massage; surgical release and skin grafting for contractures limiting function; laser therapy (fractional CO2 or PDL) for scar remodeling.

🎓 Patient Education / Summary

The following information is intended to assist clinical documentation specialists in understanding how to communicate these conditions to non-coder stakeholders and patients. This summary is not medical advice.

What Patients Should Know About Disease Complications

For Diabetic Patients: Diabetes can affect many organ systems over time. The kidneys, eyes, nerves, and circulation can all be damaged by long-term high blood sugar. Each of these complications requires specific documentation in the medical record so that insurance and Medicare can accurately reflect how complex a patient’s health situation is. Patients should know that their entire medical history matters — even “old” problems like a prior stroke or a healed fracture — because residual effects are still coded and still matter for care planning.

For Stroke Survivors: A stroke is an acute medical emergency, but the effects of a stroke — weakness, difficulty speaking, trouble swallowing — can last a lifetime. These lasting effects are called “sequelae.” It is important that these residual conditions are documented at every visit, not just when they are actively being treated. The side of the body affected (right or left) and which hand the patient uses dominantly are important details that affect coding accuracy and payment for rehabilitation services.

For Patients with COPD: COPD is a chronic disease that can worsen with infections or environmental triggers. When COPD gets worse — called a “flare-up” or exacerbation — it may require hospitalization. Whether the flare-up is caused by an infection (pneumonia, bronchitis) or by other triggers matters for how it is coded. Patients should inform their care team about any respiratory infections, changes in sputum, or increased breathing difficulty so these can be properly documented and treated.

For Trauma Patients: After an injury, medical coding uses different codes depending on where you are in the healing process. “Initial encounter” is for when you first receive treatment. “Subsequent encounter” is for follow-up during healing. “Sequela” means the injury has healed but you have a lasting complication — like a scar, stiff joint, or chronic pain. These distinctions are important for insurance coverage of rehabilitation, pain management, and surgical correction of late complications.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)